Press "Enter" to skip to content

Pelzman’s Picks: Do Rich People Get More Mental Health Meds?

  • A recent analysis revealed that wealthier individuals are purchasing more prescription drugs to treat mental disorders and other serious conditions than their less wealthy peers, write Kevin Quealy and Margot Sanger-Katz ~ The Prescription Drugs That Rich People Buy (New York Times)
  • “A new world of pain treatment is on the horizon,” writes Laura Landro who explores recent advances in measuring, understanding, and treating pain ~ A New Prognosis for Pain Care (The Wall Street Journal)
  • Mark R. Katlic, MD, and colleagues explore strategies to determine how well older surgeons are performing ~ Assessing the Performance of Aging Surgeons (JAMA)
  • Almost half of recently approved generic drugs are not available in the U.S., write Sydney Lupkin and Jay Hancock ~ Trump Administration Salutes Parade Of Generic Drug Approvals, But Hundreds Aren’t For Sale (Kaiser Health News)
  • Richard B. Weinberg, MD, reflects on managing a physician who was “susceptible to bouts of dark pessimism” ~ A Thousand Blessings (Annals of Internal Medicine)
  • Peter A. Ubel, MD, and Meredith B. Rosenthal, PhD, discuss what it will take to make healthcare better ~ Beyond Nudges — When Improving Health Calls for Greater Assertiveness (New England Journal of Medicine)
  • “I briefly believed that outing myself as a person with a disability was enough, but quickly realized that the barriers for faculty members with disabilities surpass personal acceptance,” writes Bonnielin Swenor, PhD, MPH, reflecting on the challenges of managing a disability ~ Losing Vision and Gaining Perspective (JAMA)

Fred N. Pelzman, MD, of Weill Cornell Internal Medicine Associates and weekly blogger for MedPage Today, follows what’s going on in the world of primary care medicine. Pelzman’s Picks is a compilation of links to blogs, articles, tweets, journal studies, opinion pieces, and news briefs related to primary care that caught his eye.